Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience.
Basak GW, Knopinska-Posluszny W, Matuszak M, Kisiel E, Hawrylecka D, Szmigielska-Kaplon A, Urbaniak-Kujda D, Dybko J, Zielinska P, Dabrowska-Iwanicka A, Werkun J, Rzepecki P, Wroblewska W, Wiktor-Jedrzejczak W.
Basak GW, et al. Among authors: rzepecki p.
Ann Hematol. 2011 May;90(5):557-68. doi: 10.1007/s00277-010-1098-7. Epub 2010 Oct 12.
Ann Hematol. 2011.
PMID: 20938660
Free PMC article.